Williams Jones & Associates Portfolio holdings
Top Buys
| 1 |
Visa
V
|
+$85M |
| 2 |
Mettler-Toledo International
MTD
|
+$79.7M |
| 3 |
Wabtec
WAB
|
+$60.6M |
| 4 |
Idexx Laboratories
IDXX
|
+$56.5M |
| 5 |
Automatic Data Processing
ADP
|
+$51.4M |
Top Sells
| 1 |
CVS Health
CVS
|
+$26.1M |
| 2 |
Signet Jewelers
SIG
|
+$22M |
| 3 |
Goodyear
GT
|
+$18M |
| 4 |
Blackstone
BX
|
+$9.22M |
| 5 |
Williams-Sonoma
WSM
|
+$7.23M |
Sector Composition
| 1 | Healthcare | 18.82% |
| 2 | Industrials | 13.57% |
| 3 | Technology | 11.96% |
| 4 | Financials | 11.11% |
| 5 | Communication Services | 10.4% |
Similar funds
Williams Jones & Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Williams Jones & Associates held 434 positions worth $3.24B, up 51% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Williams Jones & Associates deployed $1.04B of net new capital in Q2 2016, opening 69 new positions and adding to 208 existing holdings. Its largest new stake was Idexx Laboratories: 657,531 shares worth $61.1M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was CVS Health, an estimated $26.1M trimmed.
- Williams Jones & Associates's largest Q2 2016 buy was Idexx Laboratories: 657,531 shares worth $61.1M.
- Williams Jones & Associates added most to Visa in Q2 2016, an estimated $85M increase.
- Williams Jones & Associates's biggest Q2 2016 reduction was CVS Health, cutting an estimated $26.1M.
- Williams Jones & Associates fully exited Signet Jewelers in Q2 2016, selling an estimated $22M.
- Williams Jones & Associates's ten largest holdings make up 25% of its $3.24B portfolio in Q2 2016.
- Williams Jones & Associates opened 69 new positions and closed 33 in Q2 2016.
- Williams Jones & Associates's portfolio value rose 51% quarter-over-quarter to $3.24B.
Based on Williams Jones & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.